Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 28, 2017; 23(12): 2201-2208
Published online Mar 28, 2017. doi: 10.3748/wjg.v23.i12.2201
Table 1 Demographic information of LC[Pos] and LC[Neg] patients n (%)
VariablesLC[Pos] patients(n = 5551)LC[Neg] patients(n = 11102)P value
Gender0.99
Male3655 (65.84)7311 (65.85)
Female1896 (34.16)3791 (34.15)
Age group (yr)0.59
< 501259 (22.68)2417 (21.77)
50-641441 (25.96)2899 (26.11)
65-791914 (34.48)3902 (35.15)
≥ 80937 (16.88)1884 (16.97)
Department< 0.01a
Surgical542 (9.76)1684 (15.17)
Medical5009 (90.24)9418 (84.83)
Number of organ failures< 0.01a
03404 (61.32)8433 (75.96)
11791 (32.26)2415 (21.75)
≥ 2356 (6.41)254 (2.29)
Comorbidity
DM2048 (36.89)4082 (36.77)0.87
HTN2454 (44.21)4895 (44.09)0.89
CAD1077 (19.40)2144 (19.31)0.89
ESRD627 (11.30)1287 (11.59)0.57
COPD1133 (20.41)2277 (20.51)0.88
Cancer1362 (24.54)2739 (24.67)0.85
Stroke980 (17.65)1944 (17.51)0.82
CHF784 (14.12)1547 (13.93)0.74
HBV14 (0.25)28 (0.25)1.00
HCV21 (0.38)35 (0.32)0.51
Cryptogenic LC[Pos]1732 (31.20)